Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
<p>Abstract</p> <p>Background</p> <p>Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants for the treatment of depression in patients with Parkinson's Disease (PD) but data on their efficacy are controversial.</p> &...
Main Authors: | Lewis Glyn, Salanti Georgia, Bakola Eleni, Skapinakis Petros, Kyritsis Athanasios P, Mavreas Venetsanos |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/10/49 |
Similar Items
-
Selective serotonin reuptake inhibitors.
by: Geddes, J, et al.
Published: (2004) -
Selective serotonin reuptake inhibitors
Published: (2004) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01) -
Selective serotonin reuptake inhibitors and spermatogenesis
by: M. N. Korshunov, et al.
Published: (2021-07-01) -
THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
by: Yu. V. Solomatin, et al.
Published: (2016-12-01)